Net profit of Indo US Bio-Tech declined 20.87% to Rs 3.45 crore in the quarter ended September 2025 as against Rs 4.36 crore during the previous quarter ended September 2024. Sales rose 39.15% to Rs 30.85 crore in the quarter ended September 2025 as against Rs 22.17 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 30.85 | 22.17 | 39 |
| OPM % | 13.48 | 23.14 | - |
| PBDT | 3.77 | 4.63 | -19 |
| PBT | 3.56 | 4.45 | -20 |
| NP | 3.45 | 4.36 | -21 |